Issue 3
FDA discussion paper would assess generative AI devices in a way similar to doctors
On August 18, the FDA published a discussion paper on regulating generative AI-enabled medical devices: benchmarks would come first, then clinical confirmation, and finally evaluation of real-world use. Manufacturers, physicians and researchers can submit comments on document FDA-2026-N-7874 until October 19.
Who is affected and how
- medtech company
- During the comment period, companies should indicate which tier of the proposed graduated assessment their product would fall into and what evidence they can provide for it.
- doctor
- Through professional organizations, physicians can have a say in what clinical confirmation generative AI tools should be required to show.
- health IT
- Teams need to assess which embedded generative functions could fall under device regulation.
- health policy
- The FDA is signaling a direction for authorizing generative AI, which may serve as a benchmark for other regulators.
Epic UGM: agent-building tools, Cosmos-based generative models, real-time prior authorization
At its user meeting in Verona, Epic presented its new AI system, Ergo, and the Cosmos Curiosity family of generative models. Updates will now arrive quarterly (previously every 18 months), and the…
hospital managerBecause of Epic's AI cost model ('tokenomics'), CIOs need to plan a separate AI budget.health ITThe quarterly release cadence and agent-building tools require faster testing and governance processes.doctorAI features built into Epic may affect everyday documentation and decision-support work.health policyAccording to STAT, Epic is weighed down by internal tension over AI strategy and succession, and is also under scrutiny over market control.licensing · United StatesFDA has authorized more than 1,500 AI devices, but evidence is lagging
By mid-August the FDA's list included more than 1,500 AI-based medical devices, and the range of oncology applications is expanding. According to analyses, the evidence behind most devices has not…
doctorAuthorized status alone does not indicate clinical benefit, so the validation behind a purchased device should be asked about separately.hospital managerIn procurement, local or prospective evidence should be requested from the vendor; the FDA list alone is not enough.medtech companyGiven the evidence gap, companies should expect stronger demands for clinical substantiation.incident · United StatesAI scribe errors: invented patient data, missed social factors, language challenges
A report says 40 percent of doctors use AI scribes, but the tools can "hallucinate" patient data; in one case a patient's record listed psychedelic mushrooms she had never taken. A medRxiv study…
doctorGenerated notes must be reviewed before signing, especially medications and medical history.hospital managerAn error-reporting and sample-based audit process should be introduced for the quality of AI notes.health ITTool performance should be tested separately for multilingual patient groups.research · United States93% of hospitals use AI, but only 44% have tested it properly
A report finds that 93% of hospitals already run AI, but only 44% have tested it properly. The AMA and CHAI urge guardrails and responsible use.
hospital managerA formal process is needed to test and oversee AI tools.health ITA validation and monitoring framework must be built for the tools in use.doctorThe AMA urges guardrails for the use of AI in healthcare.Hungary
More key stories of the week
AI now decides access to care in six US states, and patients are being harmed
An AI pilot programme in six US states aims to curb 'wasteful' procedures, and reports say patients are paying the price.
doctorThe reasons given for prior-authorisation denials and the option to appeal should be documented.hospital managerIn the affected states, appeals and administrative capacity should be expanded.health policyPatient harm linked to the programme may prompt calls for regulatory intervention.insurance · AsiaChina to reimburse AI-assisted diagnoses through national health insurance
From 1 April 2026, China is the first country to reimburse AI-assisted diagnoses through national health insurance; the report cites 837 leading hospitals.
health policyThe reimbursement model is an example of how to finance AI-assisted diagnostics.hospital managerReimbursement shows the economic incentive for using AI.regulation · United StatesFDA's predetermined change control plan (PCCP) may play a growing role for AI devices
Industry summaries say the FDA's PCCP tool can speed up updates to AI-based devices by specifying in advance which modifications are authorized. According to a legal analysis, the FDA may give…
medtech companyScheduled, pre-approved frameworks for model updates should already be planned at the time of submission.health ITVendors should be asked for the change limits set out in their PCCP, so it is clear what can be updated without separate authorization.clinical deployment · United StatesAI scribe rollouts can ease burnout, but clinicians must be won over to use them
Mass General Brigham's AI scribe pilot significantly reduced burnout in early results, but the harder part was getting physicians to actually use it. Experience at Houston Methodist, Penn Medicine…
doctorBurnout relief depends on regular use, so ask for training and a feedback channel at rollout.hospital managerAfter the pilot, track utilization metrics and the rollout model; buying the tool is not enough.regulation · United StatesRegulating AI therapists: California lawmakers and the limits of unauthorized-practice rules
California lawmakers are trying to set limits on AI "therapists", while legal analyses say unauthorized-practice rules are of limited use for regulating mental health AI. According to the WSJ, the…
doctorPsychiatrists and therapists should track which tools are classified as therapeutic activity.health policyA ban on unauthorized practice does not on its own cover mental health chatbots, so a targeted rule is needed.health ITCompanies building mental health chatbots must expect requirements that differ from state to state.case · United StatesMore people ask AI about health problems, while trust and data quality remain open questions
Consumer Reports examines whether people can trust AI with health questions, while other reports say millions of Americans ask it for medical help but bad data stands in the way. STAT writes of an…
doctorIt is worth asking at appointments whether the patient has used AI, and helping them understand its limits.insurance · United StatesPrior authorization data goes public as health systems test real-time checks through Epic
Insurers' 2025 prior authorization data is now public, and the CMS Interoperability and Prior Authorization final rule gives stakeholders guidance. Health systems are testing real-time prior…
hospital managerHospital leaders can use the public authorization data in negotiations with insurers and when redesigning workflows.health ITThe CMS rule and real-time checks are reshaping priorities for integrating EHRs with payers.health policyThe rule's practical impact can now be measured from the public data.drug development · AsiaTCS launches agentic AI platform for drug development and clinical trials
TCS has launched an agentic AI platform to transform drug development and, under the name AgentHub, is bringing AI workers into clinical trials. The company is building the platform in India to speed…
pharmaceuticalsAgentic automation options should be mapped with trial sponsors and CRO partners.insurance · United StatesR1 to acquire Humata Health to automate prior authorization
R1 announced on August 18 that it will acquire Humata Health, adding AI-powered prior authorization automation and payer-provider collaboration to its Phare OS platform.
hospital managerR1 customers need to agree on the rollout timing of the new features and their effect on existing revenue cycle processes.health ITConsolidation toward prior authorization automation is gaining pace in the revenue cycle software market.tool · United StatesOracle Health adds coding and chart review tools to its clinical AI agent
Oracle Health is adding new coding and chart review capabilities to its clinical AI agent. Seema Verma spoke about rebuilding the EHR for the AI era.
doctorThe agent can take over coding and chart review tasks; accuracy should be checked before use.health ITOracle Health customers need to assess the deployment requirements and integration of the new agent.hospital managerThe cost and revenue effects of coding automation are best measured in a pilot.drug development · globalClinical evidence for AI drug discovery remains 'disappointingly limited' after a decade
One article says AI-based drug discovery still has little clinical evidence after a decade. Another analysis calls for a tougher test for AI models.
pharmaceuticalsFor AI-based projects, clinical-level metrics should be specified to justify the investment.clinical deployment · United KingdomHarrogate becomes first NHS trust to use AI to help breast cancer patients start treatment sooner
Harrogate and District NHS Foundation Trust is the first to introduce AI technology that helps breast cancer patients start treatment earlier. The news was published on 18 August.
doctorOther trusts may consider similar rollouts to speed up the oncology pathway.hospital managerThe Harrogate example is a model project for cutting the time from diagnosis to treatment.